KCNK3 and hepatocellular carcinoma: Recent studies have demonstrated that the acid-sensing potassium channel KCNK3 impact various cancer types, such as prostate cancer 37, pancreatic cancer 38, hepatocellular carcinoma (HCC) 39, and NSCLC 40.